AbbVie stock forecast and price prediction
Updated on:
Jan 27th, 2021
2
AbbVie forecast brief
- After marking all-time highs on January 20, AbbVie closed at $108.80 going down a -1.54%
- AbbVie dropped a -2.21% in 4 consecutive sessions in red
- From the chart point view, price is drawing a scaled uptrend since last October with higher tops and higher bottoms. This rally marked a 39.13% gain
AbbVie stock price forecast
Nobody knows how much a share will be priced tomorrow. Banks and financial organisations post their analysis predicting how a particular stock will performance in the future.
The following table shows the price target published by brokerage institutions for the last 30 days. Again, these predictions are not direct recommendations for small investors and should not be followed blindly.
In the last month we couldn't find any price target posted for AbbVie stock.
Analysts recommendations
In the previous month we couldn't find any rating for AbbVie
Earnings and financials
AbbVie Inc. ($ABBV) reported quarterly earnings of $2.83 per share last October, matching the Wall St consensus estimate of $2.76 per share. The company reported turnover for Q3 was $12.9 billion in line with analysts' forecasts as well.
This compares to Earnings of $2.33 per share same quarter last year, so reported EPS means a gain of 21.46%. Sales exploded a 52.16% on an annualized basis in the , from $84.8B to $129.0B last quarter.AbbVie ($ABBV) will host the earnings call on Friday next week. Estimated for this quarter is $2.85, compared to $2.83 that was reported for Q3.
AbbVie stock: buy or sell?
Is AbbVie good stock to buy now?
AbbVie had no ratings in the last 30 days Read the article to get additional tips on trading ABBV stock.In the current situation of AbbVie there is not any eligible buy setup. This doesn't mean $ABBV will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
Is it time to sell AbbVie stock?
Currently, AbbVie stock doesn't match any of our preferred sell setups, so if you own AbbVie shares and your operation is in profit probably is not time to sell now
AbbVie stock price action predictions
Since last October, AbbVie has been drawing an uptrend that so far marked an amazing 39.13%. The price line shows higher tops and bottoms, and along the way gave very few buying opportunities for those who wanted to invest. Latest pullback was in mid-December, when price bounced at $100.38. Like in all uptrends, price needs to rest and now price is moving in a range between $113.10 and $100.38
$ABBV at All-time Highs
AbbVie did it again, and marked all-time highs (ATH) on January 20 at $113.10. Stock cracked new all-time highs 3 times in the last 2 weeks
SMAs overview
Supports and resistances
The current resistance levels are:
The current support levels are:
Bollinger bands
Since the price surpassed the upper band on January 19, the price has corrected downwards by 3.13%
Relative strength index
The RSI dropped below the overbought level of 70 last Thursday after just crossing to the overbough zone for just one day (weak signal). The RSI reading on Tuesday was 55.68. Since that level was lost, AbbVie shares dropped a 3.39%
AbbVie stock price history
AbbVie started trading priced at an adjusted price1 of $24.60 on Jan 2013. Since then, ABBV stock surged by 342.28%, with an average of 42.79% per year. An investment of thousand dollars at that time would worth $4,422.76 nowadays.
1: Adjusted price after possible price splits or reverse-splits
Disclaimer:
The viewpoints published in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this article does not have an understanding of the particular positions of the reader, his or her own finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are published for general educational reasons onlyAbbVie summary
Tuesday, January 26th, 2021 | |
---|---|
Open | $111.3 |
Close | $108.8 |
Day range | $108.56 - $111.3 |
Previous close | $110.5 |
Session gain | -1.54% |
Average true range | $2.70 |
50d mov avg | $104.42 |
100d mov avg | $95.41 |
200d mov avg | $92.45 |
Earnings date | February 5th, 2021 |
Frequently asked questions
What is AbbVie stock symbol?
Will ABBV go up?
Latest AbbVie news
- Seeking AlphaAbbVie Should Benefit From A Buffett BounceNov 19, 2020